Loading clinical trials...
Loading clinical trials...
The Use of Intraoperative Mitomycin-C During Photorefractive Keratectomy and Its Effect on Postoperative Topical Steroid Requirements
Conditions
Interventions
Mitomycin-C
Fluorometholone 1% topical ocular steroid
Locations
1
United States
Navy Warfighter Refractive Surgery Center
San Diego, California, United States
Start Date
August 1, 2014
Primary Completion Date
January 1, 2023
Completion Date
July 1, 2023
Last Updated
April 15, 2022
NCT06174376
NCT03504800
NCT01243931
NCT05694247
NCT04120389
NCT01901614
Lead Sponsor
United States Naval Medical Center, San Diego
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions